Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2007
11/29/2007WO2007136013A1 Bubble generation device and microbubble tester with the bubble generation device
11/29/2007WO2007135896A1 Cell selection apparatus
11/29/2007WO2007135571A2 Blood group antigens of different types for diagnostic and therapeutic applications
11/29/2007WO2007135408A1 Impurities of donepezil
11/29/2007WO2007135385A1 Chemically defined culture medium for neisseria
11/29/2007WO2007135367A2 Screen for inflammatory response molulators
11/29/2007WO2007135363A1 Electrochemical cell
11/29/2007WO2007135306A1 Method of observation and of measurement of the dripping capability in products used as electrophoresis bath and its implementation.
11/29/2007WO2007135099A1 Detection method for influenza viruses
11/29/2007WO2007134850A2 Method and device for measuring the pollutants in exhaust gases of internal combustion engines
11/29/2007WO2007134818A2 Method for diagnosing mitochondrial dysfunction
11/29/2007WO2007134779A1 Use of protein s100a 12 as a marker for colorectal cancer
11/29/2007WO2007134761A1 Method for detecting viability
11/29/2007WO2007134711A1 Drugs analysis in doping control
11/29/2007WO2007134683A1 Method and means for the enzymatic determination of ethanol
11/29/2007WO2007134613A1 Modulation of gpr120 activity in adipocytes/fat tissue
11/29/2007WO2007134538A1 Rat antihuman macrophage migration inhibitory factor monoclonal antibody and its application
11/29/2007WO2007134460A1 Pancreatic b-cells expressing abca1 and uses thereof
11/29/2007WO2007134449A1 Screening methods for amyloid beta modulators
11/29/2007WO2007134395A1 Detection method
11/29/2007WO2007134386A1 Diagnostic agents and uses therefor
11/29/2007WO2007115541A3 Method for producing surface structures and element having a surface structure for use in biosensors or for the production of cell guiding structures
11/29/2007WO2007112215A3 Optical design of a measurement system having multiple sensor or multiple light source paths
11/29/2007WO2007112214A3 Dual function measurement system
11/29/2007WO2007109823A3 Peptide library
11/29/2007WO2007107151A3 Diagnostic test system for the simultaneous, quantitative detection of hiv1 and hiv2 antibodies and/or hiv antigens in human sample material
11/29/2007WO2007106892A3 Combined targeted therapy for the treatment of proliferative disease
11/29/2007WO2007103455A3 Genetic packages and uses thereof
11/29/2007WO2007102146A3 Methods and compositions for identifying a cell phenotype
11/29/2007WO2007092665A3 Total organic carbon analysis
11/29/2007WO2007092664A3 Blocker reagent for reduction of heterophile interferences
11/29/2007WO2007092378A3 Methods to identify immune response modulators
11/29/2007WO2007091881A3 Methods and means for detection of mycobacterium leprae infections
11/29/2007WO2007090872A3 Antibodies against secreted fri zzled related protein-4 (sfrp-4 )
11/29/2007WO2007088446A3 A process and a reagent kit for the examination of the metabolic state related to the carbohydrate and lipid metabolism of a human organism
11/29/2007WO2007087493A3 Pde11a mutations in adrenal disease
11/29/2007WO2007085913A3 Method for spectroscopy of surface plasmons in surface plasmon resonance sensors and element for the use of thereof
11/29/2007WO2007084446A3 Systems and methods for monitoring immune responses and predicting outcomes in transplant recipients
11/29/2007WO2007081565A3 Ammonia sensor and system for use
11/29/2007WO2007079953A3 In vitro method to predict the tumor sensitivity to pharmacotherapy and endoradiotherapy
11/29/2007WO2007076523A3 Markers and methods for assessing and treating psoriasis and related disorders
11/29/2007WO2007075873A3 Protein engineering strategies to optimize activity of surface attached proteins
11/29/2007WO2007072009A3 Container with rfid device for storing test sensors
11/29/2007WO2007069264A3 Reference standards for determining the purity of telithromycin and processes therefor
11/29/2007WO2007068985A3 Diagnosis and prognosis of colorectal cancer
11/29/2007WO2007064902A3 Mass spectrometry assays for acetyltransferase/deacetylase activity
11/29/2007WO2007064720A3 Sour/acid taste receptor assays, genes and proteins
11/29/2007WO2007050741A3 Compositions for treating fragile x and other disorders methods of use thereof and screening for compounds for fragile x and other disorders
11/29/2007WO2007050588A3 Systems and methods for characterizing conditions of organs for transplantation
11/29/2007WO2007048107A3 Proteomic profiling of mast cell tumors and related methods, proteins and nucleic acid molecules
11/29/2007WO2007045511A3 Deregulated genes and/or processes in inflammatory arthritis
11/29/2007WO2007038757A3 Methods and compositions for non-invasive assessment of gene expression
11/29/2007WO2007035930A3 Glycosylated polypeptides produced in yeast mutants and methods of use thereof
11/29/2007WO2007035579A3 Methods and compositions for production of methane gas
11/29/2007WO2007035498A3 Devices and methods for magnetic enrichment of cells and other particles
11/29/2007WO2007034465A3 Use of il-1f5 for the modulation of an immune-mediated response
11/29/2007WO2007018550A3 Compositions and methods for the detection of hiv-1/hiv-2 infection
11/29/2007WO2007014318A3 Zebrafish models of acute myelogenous leukemia
11/29/2007WO2007014001A3 Multiplex determination of lipid specific binding moieties
11/29/2007WO2006116167A9 Method for determination of glycoprotein ibalpha (gpibalpha) protein
11/29/2007WO2006015368A3 Molecules with effects on cellular development and function
11/29/2007WO2005116226A3 Nanoparticles comprising rna ligands
11/29/2007WO2005101981A3 Autonomous molecular computer diagnoses molecular disease markers and administers requisite drug in vitro
11/29/2007WO2005098450A3 Methods and compositions for use in evaluating and treating neoplastic disease conditions
11/29/2007WO2005010198A3 Protein logic gates
11/29/2007WO2005003294A3 Unnatural reactive amino acid genetic code additions
11/29/2007US20070277249 Animal Selected For Lacking Heparan Sulfate-3-O-Sulfotransferase-1 and Uses Thereof
11/29/2007US20070276621 Method of Reducing the Effect of Direct Interference Current in an Electrochemical Test Strip
11/29/2007US20070276610 Method for classifying genetic data
11/29/2007US20070276351 Device for bio-affinity material
11/29/2007US20070276209 Blood-Sugar Level Measuring Device
11/29/2007US20070276208 Process for identifying and treating specified cell types
11/29/2007US20070276140 Chiral 1,8-Diarylnaphthalenes, Methods of Making Them, and Their Use as Sensors
11/29/2007US20070276133 5-hydroxytryptophol (5-HTOL) derivatives, antibodies, immunoassays and detection of recent alcohol consumption
11/29/2007US20070276129 Modular molecular clasps and uses thereof
11/29/2007US20070276126 Cell adhesion and extracellular matrix proteins
11/29/2007US20070276024 Methods for Treating Diseases and Conditions with Inverse Agonists and for Screening for Agents Acting as Inverse Agonists
11/29/2007US20070276003 Biphenyl-2-ylcarbamic acid 1-{7-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]heptyl}piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, chronic obstructive pulmonary disease and asthma
11/29/2007US20070275924 Synthetic Lipid Rafts and Methods of Use
11/29/2007US20070275902 Treatment of Phosphatidylinositol Phospholipid Disorders
11/29/2007US20070275890 Chaperonin 10 Modulation Of Toll-Like Receptor-Inducible Cytokine And Chemokine Secretion
11/29/2007US20070275888 Preventive/Remedy for Cancer
11/29/2007US20070275885 Microcystins as agents for treatment of cancer
11/29/2007US20070275880 Virally-Safe Factor VIII with a Low Content of Higher Multimers
11/29/2007US20070275878 No-modified hemoglobins and uses therefor
11/29/2007US20070275483 Biomarker isolation and use thereof to characterize physiological state
11/29/2007US20070275482 Analysis method for substance
11/29/2007US20070275481 Methods For Detecting Half-Antibodies Using Chip Based Gel Electophoresis
11/29/2007US20070275480 Assay Chip, and Uses of Said Assay Chip to Determine Molecular Structures and Functions
11/29/2007US20070275477 Assays of Molecular or Subcellular Interactivity Using Depolarization After Resonance Transfer Energy (DARET)
11/29/2007US20070275476 Diagnostic Test Strip For Collecting And Detecting An Analyte In A Fluid Sample And Method For Using The Same
11/29/2007US20070275473 Chemical sensor inference network for false alarm
11/29/2007US20070275472 Method for detecting presence of silver-containing antimicrobial agents
11/29/2007US20070275467 Method and Device for Determining if a Product is in Condition for Use or Consumption
11/29/2007US20070275456 Diagnostic Testing Apparatus
11/29/2007US20070275442 Side Chain Deuterated Amino Acids Methods Of Use
11/29/2007US20070275440 Regulation of transcription factor, nf-il6/lap
11/29/2007US20070275434 Bioassay determining carboplatin and paclitaxel (Taxol) chemosensitivity of epithelial ovarian cancer cells, where measurements of caspase-3 activation are surrogate markers for activation of chemotherapy-induced programmed cell death
11/29/2007US20070275433 perturbation-sensitive constructs that comprises a polydiacetylene; provides a colorimetric/fluorescent sensor of membrane perturbations that may be incorporated into the cell membrane of living cells
11/29/2007US20070275431 Detection of Preterm Labour
1 ... 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 ... 3937